Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv–UroCCR 79 Study
-
Published:2023-02
Issue:1
Volume:21
Page:194-202
-
ISSN:1558-7673
-
Container-title:Clinical Genitourinary Cancer
-
language:en
-
Short-container-title:Clinical Genitourinary Cancer
Author:
Rolley CyrielleORCID,
Barthelemy Philippe,
Bensalah Karim,
Nouhaud François-Xavier,
Villers Arnauld,
Bruyère Franck,
Lebdai Souhil,
Ricard Solène,
Gross-Goupil Marine,
Rouprêt Morgan,
Bernhard Jean-Christophe,
Bigot Pierre